Elevian is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.
Investor Activity
Elevian has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
September 17, 2021
29
53%
$43 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Elevian is developing and marketing.
Elevian doesn't have any recent trademark applications, indicating Elevian is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ELEVIAN pharmaceutical preparations for the treatment and prevention of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes; transdermal drug delivery patches sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; implantable subcutaneous or intramuscular drug delivery devices sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; medical devices, namely, implantable or external pumps sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes for delivering drugs
08/31/2018
See all trademarks and details in the Full Report.
Market Share of Elevian's Largest Competitors
A competitive analysis shows these companies are in the same general field as Elevian, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Elevian.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Elevian and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.